Post-Transfusion Hepatitis C Virus Infection

Steven Kleinman; Michael Busch; Paul Holland; Kenrad E. Nelson; James G. Donahue; Veronica Stambolis

doi:10.1056/NEJM199211263272216

Post-Transfusion Hepatitis C Virus Infection

Steven Kleinman, Michael Busch, Paul Holland, Kenrad E. Nelson, James G. Donahue, Veronica Stambolis

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

Abstract

To the Editor: The report by Donahue et al. (Aug. 6 issue)¹ documented the dramatic decrease in the risk of transmitting hepatitis C virus (HCV) through blood transfusion as a result of sequential improvements in blood-donor testing over the past five years. The authors' data included measurements of the risk of HCV from blood screened by tests for surrogate markers of non-A, non-B hepatitis (antibody to the hepatitis B core antigen [anti-HBc] and elevated levels of alanine aminotransferase) and by a first-generation enzyme immunoassay (EIA) for antibodies to HCV (anti-HCV). The authors stated that the recent implementation of a second-generation…

Original language	English (US)
Pages (from-to)	1601-1602
Number of pages	2
Journal	New England Journal of Medicine
Volume	327
Issue number	22
DOIs	https://doi.org/10.1056/NEJM199211263272216
State	Published - Nov 26 1992

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJM199211263272216

Fingerprint Dive into the research topics of 'Post-Transfusion Hepatitis C Virus Infection'. Together they form a unique fingerprint.

Cite this

@article{0ccb340a9eb54b6fb6a0a5896d034544,

title = "Post-Transfusion Hepatitis C Virus Infection",

abstract = "To the Editor: The report by Donahue et al. (Aug. 6 issue)1 documented the dramatic decrease in the risk of transmitting hepatitis C virus (HCV) through blood transfusion as a result of sequential improvements in blood-donor testing over the past five years. The authors' data included measurements of the risk of HCV from blood screened by tests for surrogate markers of non-A, non-B hepatitis (antibody to the hepatitis B core antigen [anti-HBc] and elevated levels of alanine aminotransferase) and by a first-generation enzyme immunoassay (EIA) for antibodies to HCV (anti-HCV). The authors stated that the recent implementation of a second-generation…",

author = "Steven Kleinman and Michael Busch and Paul Holland and Nelson, {Kenrad E.} and Donahue, {James G.} and Veronica Stambolis",

year = "1992",

month = nov,

day = "26",

doi = "10.1056/NEJM199211263272216",

language = "English (US)",

volume = "327",

pages = "1601--1602",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "22",

}

TY - JOUR

T1 - Post-Transfusion Hepatitis C Virus Infection

AU - Kleinman, Steven

AU - Busch, Michael

AU - Holland, Paul

AU - Nelson, Kenrad E.

AU - Donahue, James G.

AU - Stambolis, Veronica

PY - 1992/11/26

Y1 - 1992/11/26

N2 - To the Editor: The report by Donahue et al. (Aug. 6 issue)1 documented the dramatic decrease in the risk of transmitting hepatitis C virus (HCV) through blood transfusion as a result of sequential improvements in blood-donor testing over the past five years. The authors' data included measurements of the risk of HCV from blood screened by tests for surrogate markers of non-A, non-B hepatitis (antibody to the hepatitis B core antigen [anti-HBc] and elevated levels of alanine aminotransferase) and by a first-generation enzyme immunoassay (EIA) for antibodies to HCV (anti-HCV). The authors stated that the recent implementation of a second-generation…

AB - To the Editor: The report by Donahue et al. (Aug. 6 issue)1 documented the dramatic decrease in the risk of transmitting hepatitis C virus (HCV) through blood transfusion as a result of sequential improvements in blood-donor testing over the past five years. The authors' data included measurements of the risk of HCV from blood screened by tests for surrogate markers of non-A, non-B hepatitis (antibody to the hepatitis B core antigen [anti-HBc] and elevated levels of alanine aminotransferase) and by a first-generation enzyme immunoassay (EIA) for antibodies to HCV (anti-HCV). The authors stated that the recent implementation of a second-generation…

UR - http://www.scopus.com/inward/record.url?scp=0026487117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026487117&partnerID=8YFLogxK

U2 - 10.1056/NEJM199211263272216

DO - 10.1056/NEJM199211263272216

M3 - Letter

C2 - 1279422

AN - SCOPUS:0026487117

VL - 327

SP - 1601

EP - 1602

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 22

ER -

Post-Transfusion Hepatitis C Virus Infection

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this